Gen7T

Gen7T is a San Diego-based biotechnology company focused on the discovery and development of next-generation precision oncology treatments. Founded by a veteran executive team with a proven track record at Receptos and Gossamer Bio, the company leverages deep expertise in G protein-coupled receptors (GPCRs) and targeted drug discovery. Gen7T utilizes a proprietary platform to identify and validate novel cancer drivers, aiming to develop highly specific small molecule therapies for patients with genetically defined tumors. The company is currently operating in stealth mode and is backed by premier life science investors, including ARCH Venture Partners. By integrating advanced genomic data with sophisticated medicinal chemistry, Gen7T seeks to address significant unmet needs in the oncology landscape.